Literature DB >> 10523462

Hyperglycemia as a risk factor for cardiovascular disease in type 2 diabetes.

M Laakso1.   

Abstract

According to several prospective population-based studies, glycemic control influences the risk for cardiovascular disease, including coronary heart disease, independently of conventional risk factors in patients with type 2 diabetes. Recent clinical trials, particularly the United Kingdom Prospective Diabetes Study, have shown that microvascular complications and macrovascular complications, although to a lesser extent, can be prevented in patients with type 2 diabetes with correction of glycemic control. However, in the treatment and prevention of cardiovascular disease in type 2 diabetes, all known cardiovascular risk factors should be attacked simultaneously.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10523462     DOI: 10.1016/s0095-4543(05)70133-0

Source DB:  PubMed          Journal:  Prim Care        ISSN: 0095-4543            Impact factor:   2.907


  16 in total

Review 1.  Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction.

Authors:  Csaba Szabo
Journal:  Br J Pharmacol       Date:  2009-02-06       Impact factor: 8.739

2.  Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix.

Authors:  Xiaoyi Zhang; James A Stewart; Ian D Kane; Erin P Massey; Dawn O Cashatt; Wayne E Carver
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-12       Impact factor: 2.416

3.  Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes.

Authors:  Marianne Tare; Rushita S R Kalidindi; Kristen J Bubb; Helena C Parkington; Wee-Ming Boon; Xiang Li; Christopher G Sobey; Grant R Drummond; Rebecca H Ritchie; Barbara K Kemp-Harper
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-01-10       Impact factor: 3.000

4.  Risk factors for cardiovascular disease in women with diabetes.

Authors:  Christine Maric
Journal:  Gend Med       Date:  2010-12

5.  High-Deductible Insurance and Delay in Care for the Macrovascular Complications of Diabetes.

Authors:  J Frank Wharam; Christine Y Lu; Fang Zhang; Matthew Callahan; Xin Xu; Jamie Wallace; Stephen Soumerai; Dennis Ross-Degnan; Joseph P Newhouse
Journal:  Ann Intern Med       Date:  2018-11-20       Impact factor: 25.391

6.  Effects of acute hyperglycemia on the exercise pressor reflex in healthy rats.

Authors:  Yu Huo; Ann-Katrin Grotle; Kai M Ybarbo; Junghoon Lee; Michelle L Harrison; Audrey J Stone
Journal:  Auton Neurosci       Date:  2020-11-05       Impact factor: 3.145

Review 7.  Impact of cigarette smoking in type 2 diabetes development.

Authors:  Xi-tao Xie; Qiang Liu; Jie Wu; Makoto Wakui
Journal:  Acta Pharmacol Sin       Date:  2009-05-11       Impact factor: 6.150

8.  Association of metabolic risk factors with cartilage degradation assessed by T2 relaxation time at the knee: data from the osteoarthritis initiative.

Authors:  P M Jungmann; M S Kraus; H Alizai; L Nardo; T Baum; M C Nevitt; C E McCulloch; G B Joseph; J A Lynch; T M Link
Journal:  Arthritis Care Res (Hoboken)       Date:  2013-12       Impact factor: 4.794

9.  In vivo and in vitro evidence of the sex-dependent pharmacokinetics and disposition of G004, a potential hypoglycemic agent, in rats.

Authors:  Linlin Hu; Janvier Engelbert Agbokponto; Xiaobing Li; Li Ding; Bing Liu; Shuisheng Zhong; Xiaoyu Zhang; Yiwei Du
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2014-04-03       Impact factor: 2.441

10.  Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Pairoj Rerkpattanapipat; Ralph B D'Agostino; Kerry M Link; Eyal Shahar; Joao A Lima; David A Bluemke; Shantanu Sinha; David M Herrington; W Gregory Hundley
Journal:  Diabetes       Date:  2009-01-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.